In light of these observations, we propose a feedback model (Figure 7) in which the SXR-CYP3A pathway is induced in response to irinotecan treatment in colon cancer cells, SXR mediated expression of detoxification genes allowing for drug resistance and tumor escape to genotoxic treatments. Here, NR1I2 is linked to colonic neoplasm.